We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Plasma Tool Reduces Damage to Surrounding Tissue

By HospiMedica International staff writers
Posted on 01 Jun 2015
Print article
The J-Plasma surgical tool
The J-Plasma surgical tool (Photo courtesy of Apyx Medical)
A new plasma-based hand piece surgical tool promotes soft tissue coagulation and cutting during open and laparoscopic procedures.

The J-Plasma tool is based on a highly defined, cool plasma stream that is used for soft tissue coagulation and cutting during surgery. The plasma stream is formed by passing an inert gas, such as helium, over a uniquely designed blade, which energizes the gas. The plasma stream generated can cut, coagulate, and ablate tissue at much cooler temperatures than traditional CO2 lasers, allowing surgeons to operate more freely in delicate areas of the body and reduce damage to surrounding tissue. The J-Plasma stream is also limited to a maximum of 15 mm in length, thus eliminating pass-through.

The distinctive design of the hand piece provides an option to retract or extend the surgical blade, providing multiple modes of operation. In the extended configuration, the surgical blade can be used without energy or plasma, similar to a scalpel for incisions and other cutting procedures. When retracted, the device can be used to form the J-Plasma stream for coagulation or blunt dissection. A combination of the J-Plasma stream with the blade extended can provide an enhanced cutting capability with minimal impact on surrounding tissue.

Surgeons treating women with endometriosis, for example, can remove diseased tissue on the fallopian tubes without fear of damaging the delicate structures. This can improve the likelihood of more effective treatment, potentially reducing the need for repeat procedures. The J-Plasma tool is a product of Bovie Medical Corporation (Clearwater, FL, USA), and has been approved by the US Food and Drug Administration (FDA).

“The extended blade can be energized while helium is flowing to provide an enhanced plasma-based electrosurgical effect which speeds the cutting action, but produces virtually no eschar,” said Rob Saron, CEO of Bovie Medical Corporation. “When the blade is retracted, it serves as the sharp conductive point to produce the plasma beam which can then be used to coagulate, affect hemostasis, desiccation, etc.”

Plasma has so far enjoyed a limited role in surgery due to the high temperatures it creates and resulting harmful effects on body tissue.

Related Links:

Bovie Medical Corporation


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pressure Transducer
TruWave
New
Needle Guide Disposable Kit
Verza
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more